必须声明标量变量 "@Script_ID"。 体外膜肺氧合技术(ECMO)在临床急危重症医学的应用进展-《赣南医学院学报》

[1]田荣成*,刘 抗*,张泽生,等.体外膜肺氧合技术(ECMO)在临床急危重症医学的应用进展[J].赣南医学院学报,2019,39(12):1207-1212.[doi:10.3969/j.issn.1001-5779.2019.12.005]
 TIAN Rong-cheng,LIU Kang,ZHANG Ze-sheng,et al.Advances in the application of extracorporeal membrane oxygenation(ECMO)in clinical critical and critical medicine[J].,2019,39(12):1207-1212.[doi:10.3969/j.issn.1001-5779.2019.12.005]
点击复制

体外膜肺氧合技术(ECMO)在临床急危重症医学的应用进展()
分享到:

《赣南医学院学报》[ISSN:1001-5779/CN:36-1154/R]

卷:
39
期数:
2019年12期
页码:
1207-1212
栏目:
心脑血管疾病·基础与临床
出版日期:
2019-12-31

文章信息/Info

Title:
Advances in the application of extracorporeal membrane oxygenation(ECMO)in clinical critical and critical medicine
文章编号:
1001-5779(2019)12-1207-06
作者:
田荣成1*刘 抗2*张泽生3唐志贤1谢春发1胡 硕1赖政洪1刘子由1
赣南医学院 1.第一附属医院; 2.2019级硕士研究生; 3.2017级硕士研究生,江西 赣州 341000
Author(s):
TIAN Rong-cheng1 LIU Kang2 ZHANG Ze-sheng3 TANG Zhi-xian1 XIE Chun-fa1 HU Shuo1 LAI Zheng-hong1 LIU Zi-you1
Gannan Medical University 1.The first affiliated Hospital; 2.Post graduate student, Grade 2019; 3.Post graduate student, Grade 2017, Ganzhou, Jiangxi 341000
关键词:
体外膜肺氧合技术 体外循环 衰竭 急危重症 心肺复苏
Keywords:
ECMO cardiopulmonary bypass exhaustion critical cardiopulmonary resuscitation
分类号:
R654
DOI:
10.3969/j.issn.1001-5779.2019.12.005
文献标志码:
A
摘要:
利用体外膜肺氧合技术(ECMO),在临床急危重症医学领域,已经取得了一定成效。在ECMO术后,患者心肺功能得以休息,各器官所需血氧经体外循环供给,并且维持较高的血氧饱和度,保护了重要器官免受缺血缺氧的损害,促进了患者身体机能的恢复。在临床心脏外科、呼吸系统疾病以及重症医学领域,发挥了重要作用。但由于ECMO技术目前仍属于新颖、精细、复杂、昂贵的治疗技术,主要开展于大型高等级综合性医院,且要求建立完善的心脏医学中心或者ECMO中心,病例数量相对较少,因此此类技术应用及研究较少。即便如此,ECMO技术在急危重症医学领域,是目前挽救患者生命不可替代的技术手段。研究ECMO技术的临床应用情况,可为将来重大疾病救治方面积累经验,以及ECMO技术的发展发挥重要作用。
Abstract:
The use of extracorporeal membrane oxygenation(ECMO)has achieved some results in the field of clinical critical medicine. After ECMO, the patients' cardiopulmonary function can rest, the blood oxygen required by each organ is supplied by cardiopulmonary bypass, and the high saturation of blood oxygen is maintained, which protects the important organs from the damage of ischemia and hypoxia, and promotes the recovery of the patient's body function. It plays an important role in clinical cardiac surgery, respiratory diseases, and critical medicine. However, ECMO technology is still novel, sophisticated, complex and expensive treatment technology, mainly developed in large high-grade general hospitals, and requires the establishment of a sound heart. The number of cases in medical centers or ECMO centers is relatively small, so the use and research of such techniques are less. Even so, ECMO technology is an irreplaceable means to save patients' lives in the field of critical and critical medicine.To study the clinical application of ECMO technology can accumulate experience for the treatment of major diseases in the future and play an important role in the development of ECMO technology.

参考文献/References:

[1] Conrad S A, Broman L M, Taccone F S, et al. The Extracorporeal Life Support Organization Maastricht Treaty for Nomenclature in Extracorporeal Life Support. A Position Paper of the Extracorporeal Life Support Organization[J]. American Journal of Respiratory and Critical Care Medicine,2018,198(4):447-451.
[2] 龙村. 体外膜肺氧合的临床应用现状和发展趋势[J].内科急危重症杂志,2013(3):132-134.
[3] What is ECMO Source[J]. Am J Respir Crit Care Med SO, 2016, 193(6):9-10[PMIDT26977974].
[4] Guimbretière G, Anselmi A, Roisne A, et al. Prognostic impact of blood product transfusion in VA and VV ECMO[J]. Perfusion, 2018, 2018:324307203.
[5] den Uil C A, Jewbali L S, Heeren M J, et al. Isolated left ventricular failure is a predictor of poor outcome in patients receiving veno-arterial extracorporeal membrane oxygenation[J]. European Journal of Heart Failure,2017,19:104-109.
[6] Sorokin V, Maclaren G, Vidanapathirana P C, et al. Choosing the appropriate configuration and cannulation strategies for extracorporeal membrane oxygenation: the potential dynamic process of organ support and importance of hybrid modes[J]. European Journal of Heart Failure,2017,19:75-83.
[7] Danial P, Hajage D, Nguyen L S, et al. Percutaneous versus surgical femoro-femoral veno-arterial ECMO: a propensity score matched study[J]. Intensive Care Medicine, 2018, 83(3):457-464.
[8] 王丽红,崔妮,卜惠弟. 体外膜肺氧合技术在危重症患儿护理中的应用进展[J].护士进修杂志,2018(5):416-418.
[9] 闫钢风,陆国平,陆铸今,等. 体外膜肺氧合在儿童急性呼吸窘迫综合征中的应用[J].中国当代儿科杂志,2018(9):701-705.
[10] Salazar P A, Blitzer D, Dolejs S C, et al. Echocardiographic Guidance During Neonatal and Pediatric Jugular Cannulation for ECMO[J]. Journal of Surgical Research,2018,232:517-523.
[11] Van Ommen C H, Neunert C E, Chitlur M B. Neonatal ECMO[J]. Frontiers in Medicine,2018,5:189-193.
[12] Carpenter T C, Kinsella J P. Waiting for Godot: Clinical Trials of Extracorporeal Membrane Oxygenation for Pediatric Respiratory Failure[J]. American Journal of Respiratory and Critical Care Medicine,2018,197(9):1103-1104.
[13] Schmidt M, Burrell A, Roberts L, et al. Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO(SAVE)-score[J]. European Heart Journal,2015,36(33):2246-2256.
[14] Rao P, Khalpey Z, Smith R, et al. Venoarterial Extracorporeal Membrane Oxygenation for Cardiogenic Shock and Cardiac Arrest[J]. Circulation: Heart Failure,2018,11(9):637-645.
[15] Dalton H J, Reeder R, Garcia-Filion P, et al. Factors Associated with Bleeding and Thrombosis in Children Receiving Extracorporeal Membrane Oxygenation[J]. American Journal of Respiratory and Critical Care Medicine,2017,196(6):762-771.
[16] 陆承,张亚军. 体外膜肺氧合在肺移植中的应用[J].中日友好医院学报,2018,32(4):227-230.
[17] Wengenmayer T, Schroth F, Biever P M, et al. Albumin fluid resuscitation in patients on venoarterial extracorporeal membrane oxygenation(VA-ECMO)therapy is associated with improved survival[J]. Intensive Care Medicine, 2018, 13(2):1-7.
[18] Meneveau N, Guillon B, Planquetle B, et al. Outcomes after extracorporeal membrane oxygenation for the treatment of high-risk pulmonary embolism: amulticentre series of 52 cases[J]. Eur Heart J, 2018, 39(47):4196-4204.
[19] 金屏,刘洋,唐嘉佑,等. 体外膜肺氧合辅助下经导管主动脉瓣置换术的临床应用研究[J].精准医学杂志,2018(2):110-114.
[20] 刘颖,柳云恩,佟昌慈,等. 体外膜肺氧合技术在临床应用中研究进展[J].创伤与急危重病医学,2016(1):24-27.
[21] 陈书弘,黑飞龙. 体外膜肺氧合在过敏性休克治疗中的应用进展[J].中国体外循环杂志,2018(1):53-55.
[22] 邓丽,张国伟,杨慧,等. 清醒体外膜肺氧合在心外科围术期的应用[J].中国体外循环杂志,2018(2):101-103.
[23] Chong S, Fang C, Fang H, et al. Associations with the In-Hospital Survival Following Extracorporeal Membrane Oxygenation in Adult Acute Fulminant Myocarditis[J]. Journal of Clinical Medicine,2018,7(11):452.
[24] Iantorno M, Ben-Dor I, Rogers T, et al. Emergent valve-in-valve transcatheter aortic valve replacement in patient with acute aortic regurgitation and cardiogenic shock with preoperative extracorporeal membrane oxygenator: A case report and review of the literature[J]. Cardiovascular Revascularization Medicine, 2018, 136:2741-2746.
[25] Brijesh, Patel, Nicholas, et al. ECMO for Severe Acute Respiratory Distress Syndrome[J]. The New England journal of medicine, 2018, 379(11):1090-1093.
[26] Simonsen C, Magnusdottir S O, Andreasen J J, et al. ECMO improves survival following cardiogenic shock due to carbon monoxide poisoning-an experimental porcine model[J]. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine,2018,26(1):608-615.
[27] Combes A, Hajage D, Capellier G, et al. Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome[J]. The New England Journal of Medicine, 2018, 378(21):1965-1975.
[28] Araos J, Alegria L, Garcia P, et al. Near-Apneic Ventilation Decreases Lung Injury and Fibroproliferation in an ARDS Model with ECMO[J]. American Journal of Respiratory and Critical Care Medicine, 2018, 15(20):26-31.
[29] 卢安东,郭剑,苗莉霞,等. 心脏术后体外膜肺氧合支持临床应用探讨[J].中国体外循环杂志,2017(2):100-104.
[30] 袁小丽,李春盛. 体外膜肺氧合的临床应用[J].中国临床医生杂志,2018,46(7):770-771.
[31] 周宁,鲍玫,王振全. 体外膜肺氧合支持治疗应用及并发症防范研究进展[J].临床误诊误治,2018(4):106-111.
[32] 孙小文,张加乐,徐思怡,等. 11例重症患者应用ECMO院间转运的管理[J].中国护理管理,2018(8):1136-1141.
[33] 解蓓蓓,王金柱,杨晓波,等. 护理目标管理策略预防VV-ECMO并发症效果观察[J].齐鲁护理杂志,2018(12):45-47.
[34] 贺丽君,谢剑锋. 体外膜肺氧合在危重症患者中的应用进展[J].解放军护理杂志,2016(22):37-39.
[35] 刘桂英,应巧燕,李若祎,等. 体外膜肺氧合治疗患者早期活动的研究进展[J].中华护理杂志,2018(6):724-729.
[36] Patroniti N, Bonatti G, Senussi T, et al. Mechanical ventilation and respiratory monitoring during extracorporeal membrane oxygenation for respiratory support[J]. Annals of Translational Medicine,2018,6(19):386.
[37] Diffuse cerebral microbleeds after e Source[J]. Am J Respir Crit Care Med SO, 2015, 191(5):594[PMIDT25723825].
[38] Balle C M, Jeppesen A N, Christensen S, et al. Platelet Function During Extracorporeal Membrane Oxygenation in Adult Patients: A Systematic Review[J]. Frontiers in Cardiovascular Medicine,2018,5:45-50.
[39] 黑飞龙. 不断提升体外循环专业的血液管理水平[J].中国体外循环杂志,2018(5):257.
[40] 侯雅琴,封永莉,张晓勤,等. 体外膜肺氧合对成人抗感染药物药动学的影响[J].实用药物与临床,2018(9):965-969.
[41] 周伯颐,楼松,龙村,等. 体外膜肺氧合联合持续性肾替代治疗对心外科危重患者预后的影响[J].心肺血管病杂志,2018(7):650-654.
[42] 龙村. 体外膜肺氧合循环支持专家共识[J].中国体外循环杂志,2014(2):65-67.
[43] 周琴. 心脏移植术后体外生命支持系统危险因素分析[D].北京:北京协和医学院,2017.
[44] 田芳,刘丹纯,陈海君,等. 心脏危重患者应用床旁紧急安置体外膜肺氧合辅助治疗的护理[J]. 岭南心血管病杂志,2018(5):595-597.
[45] Pappalardo F, Schulte C, Pieri M, et al. Concomitant implantation of Impella on top of veno-arterial extracorporeal membrane oxygenation may improve survival of patients with cardiogenic shock[J]. European Journal of Heart Failure,2017,19(3):404-412.
[46] Posluszny J, Rycus P T, Bartlett R H, et al. Outcome of Adult Respiratory Failure Patients Receiving Prolonged(≥14 Days)ECMO[J]. Annals of Surgery,2016,263(3):573-581.
[47] Barbaro R P, Odetola F O, Kidwell K M, et al. Association of Hospital-Level Volume of Extracorporeal Membrane Oxygenation Cases and Mortality. Analysis of the Extracorporeal Life Support Organization Registry[J]. American Journal of Respiratory and Critical Care Medicine,2015,191(8):894-901.
[48] 章晓华,庄建. 中国体外膜肺氧合技术开展的现状及思考[J].中国体外循环杂志,2017(2):68-71.
[49] 黑飞龙,陈书弘. 紧跟时代步伐促进体外循环学科发展[J].中国体外循环杂志,2018(1):1-2.
[50] 黑飞龙,龙村. 中国体外循环教育的现状和思考[J].中国体外循环杂志,2014(1):1-2.

备注/Memo

备注/Memo:
基金项目:国家自然科学基金课题(编号:H1502,81360287)
通信作者:刘子由,男,博士,教授,主任医师,研究方向:心脏大血管外科。E-mail:ziyoudoc@163.com
更新日期/Last Update: 2019-12-30